FDA Cites Benefits of Merck HIV Drug
(AP) -- A new HIV-fighting drug from Merck & Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - HIV & AIDS: $19 million grant to fund center aimed at unlocking biological structure of HIV

Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!


PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback